Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 47 positions · Total reported value $2.29B · Top-10 concentration 76.4% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.5% · 6 new · 5 cut · 2 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, Casdin Capital disclosed 47 equity positions with a combined reported value of $2.29B. The filing implies a focused portfolio: its ten largest positions account for 76.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($529.02M), RLAY ($289.44M), WGS ($268.03M). By sector, the heaviest allocations are Health Care 91.4%, Industrials 7.1%. Versus the prior quarter, allocation shifted toward Technology (+1.5pp), Industrials (+1.4pp) and away from Health Care (-2.9pp).

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 5 and fully exited 2, a turnover rate of 26.5% of positions. The portfolio's overlap with the prior quarter was 84% of names.

The largest new positions opened in Q3 2026 were TEM ($34.69M), ORIC ($16.84M), BIIB ($11.29M).

Of the 2 positions fully exited versus the prior quarter, the largest were SION ($17.60M), IRON ($4.75M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • TEM TEMPUS AI INC · $34.69M
  • ORIC ORIC PHARMACEUTICALS INC · $16.84M
  • BIIB BIOGEN INC · $11.29M
  • EWTX EDGEWISE THERAPEUTICS INC · $10.76M
  • BNTX BIONTECH SE · $8.36M
  • RAPP RAPPORT THERAPEUTICS INC · $6.72M

Fully Exited (vs previous quarter)

  • SION SIONNA THERAPEUTICS INC · prev qtr: $17.60M
  • IRON DISC MEDICINE INC · prev qtr: $4.75M

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 47 US equity positions with a combined value of $2.29B. HoldingsHub carries 44 quarters of its filings (Q4 2015–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 47 positions · $2.29B reported value (Q3 2026)
  • Top 10 holdings = 76.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 23.1%
  • Average position size: $48.67M

Sector Tilt

  • Health Care 91.4%
  • Industrials 7.1%
  • Information Technology 1.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 6 new, 8 added, 5 reduced, 2 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Casdin Capital increased exposure to biotech/healthcare (e.g., GRAL, NGNE, SRRK) while trimming some existing positions (BLFS), suggesting a bullish view on innovative therapeutics but selective profit-taking. 2. Key moves: - Added: GRAL (+41.7% shares), NGNE (+2.6% shares), SRRK (+27.8% shares). - Reduced: BLFS (-3.3% shares). 3. Portfolio structure: Active, concentrated (47 positions), heavily biased toward Health Care (9/10 top holdings), with moderate risk appetite (high-conviction biotech bets). 4. Per-holding one-liner: - RVMD: Revolution Medicines (cancer therapeutics). - RLAY: Relay Therapeutics (drug discovery). - WGS: Genedx Holdings (genetic testing). - BLFS: Biolife Solutions (cell preservation). - ILMN: Illumina (genomic sequencing). - GRAL: Grail (early cancer detection). - TXG: 10x Genomics (genomics tools). - LAB: Standard Biota (synthetic biology). - NGNE: Neurogene (gene therapy). - SRRK: Scholar Rock (muscle disease drugs). 5. Style summary: Biotech-focused active manager selectively increasing exposure to high-growth therapeutic platforms while trimming select positions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 10:09

Sector Allocation

Health Care 91.4%
Technology 1.5%
Other 0.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.58M $529.02M 23.12%
23.12%
Hold
2 16.04M $289.44M 12.65%
12.65%
Hold
3 3.71M $268.03M 11.72%
11.72%
Hold
4 4.50M $174.82M 7.64%
7.64%
Reduce
5 530.00K $145.05M 6.34%
6.34%
Hold
6 680.00K $95.28M 4.17%
4.17%
Add
7 1.05M $94.88M 4.15%
4.15%
Hold
8 88.78M $65.75M 2.87%
2.87%
Hold
9 1.59M $44.10M 1.93%
1.93%
Add
10 850.00K $41.07M 1.79%
1.79%
Add
11 2.30M $37.44M 1.64%
1.64%
Reduce
12 1.50M $36.67M 1.60%
1.60%
Add
13 423.60K $34.69M 1.52%
1.52%
New
14 1.82M $33.16M 1.45%
1.45%
Add
15 185.00K $33.00M 1.44%
1.44%
Hold
16 1.03M $32.21M 1.41%
1.41%
Reduce
17 120.00K $29.61M 1.29%
1.29%
Add
18 1.25M $25.84M 1.13%
1.13%
Reduce
19 800.00K $23.83M 1.04%
1.04%
Add
20 843.86K $22.94M 1.00%
1.00%
Hold
21 553.27K $21.65M 0.95%
0.95%
Hold
22 645.69K $20.85M 0.91%
0.91%
Hold
23 1.25M $20.00M 0.87%
0.87%
Hold
24 3.90M $18.99M 0.83%
0.83%
Add
25 1.55M $17.20M 0.75%
0.75%
Hold
26 1.25M $16.84M 0.74%
0.74%
New
27 75.00K $14.44M 0.63%
0.63%
Hold
28 276.31K $12.72M 0.56%
0.56%
Hold
29 50.00K $11.65M 0.51%
0.51%
Hold
30 50.00K $11.29M 0.49%
0.49%
New
31 265.00K $10.76M 0.47%
0.47%
New
32 973.26K $10.48M 0.46%
0.46%
Hold
33 3.17M $9.68M 0.42%
0.42%
Hold
34 85.00K $8.36M 0.36%
0.36%
New
35 200.00K $6.72M 0.29%
0.29%
New
36 355.00K $4.28M 0.19%
0.19%
Hold
37 150.00K $3.62M 0.16%
0.16%
Hold
38 1.23M $2.10M 0.09%
0.09%
Hold
39 148.33K $1.99M 0.09%
0.09%
Hold
40 723.77K $1.72M 0.07%
0.07%
Hold
41 282.31K $1.16M 0.05%
0.05%
Hold
42 445.00K $1.14M 0.05%
0.05%
Hold
43 86.01K $1.03M 0.04%
0.04%
Reduce
44 50.00K $737.50K 0.03%
0.03%
Hold
45 165.32K $682.78K 0.03%
0.03%
Hold
46 36.49K $468.20K 0.02%
0.02%
Hold
47 361.97K $218.48K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 21% of its Top-10 each quarter and backtests at F1 80% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (42 quarters)

Avg precision 80% · recall 80% · F1 80% · avg rank error 2.3 · Top-10 turnover 21%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2016-Q2 70% 70% 70% EPZM · FMI · LOXO · AGIO · SAGE · ALNY · BLUE · BPMC · MYOK · ONCE ONCE · AGIO · FMI · GBT · LOXO · BPMC · BLUE · EVH · ALNY · KITE
2016-Q3 80% 80% 80% AGIO · ONCE · FMI · GBT · LOXO · BPMC · BLUE · EVH · ALNY · KITE AGIO · SAGE · FMI · EVH · BPMC · LOXO · GNMK · ONCE · GBT · KITE
2016-Q4 80% 80% 80% AGIO · SAGE · EVH · FMI · BPMC · GNMK · LOXO · GBT · ONCE · KITE SAGE · LOXO · AGIO · FMI · EVH · BPMC · ONCE · GNMK · BLUE · VYGR
2017-Q1 90% 90% 90% SAGE · LOXO · AGIO · FMI · EVH · BPMC · GNMK · ONCE · VYGR · BLUE SAGE · FMI · LOXO · AGIO · BPMC · EVH · EPZM · ONCE · VYGR · GNMK
2017-Q2 70% 70% 70% SAGE · FMI · LOXO · AGIO · EVH · BPMC · EPZM · ONCE · VYGR · GNMK LOXO · SAGE · FMI · BPMC · EVH · AGIO · SGMOQ · CLVSQ · XBI · ONCE
2017-Q3 60% 60% 60% LOXO · SAGE · FMI · BPMC · SGMOQ · CLVSQ · AGIO · XBI · EVH · ONCE LOXO · MYOK · ALNY · SGMOQ · BPMC · BLUE · FMI · KITE · ONCE · AGIO
2017-Q4 80% 80% 80% LOXO · ALNY · MYOK · BLUE · SGMOQ · KITE · BPMC · ONCE · FMI · VYGR SAGE · FMI · LOXO · BPMC · BLUE · ALNY · MYOK · SGMOQ · GBT · VYGR
2018-Q1 80% 80% 80% SAGE · FMI · LOXO · BLUE · ALNY · BPMC · MYOK · SGMOQ · GBT · VYGR LOXO · FMI · SAGE · BPMC · ONCE · AGIO · ALNY · GBT · MYOK · SGMOQ
2018-Q2 70% 70% 70% LOXO · FMI · SAGE · ONCE · AGIO · BPMC · GBT · ALNY · FATE · MYOK FMI · SAGE · MYOK · ONCE · BLUE · AGIO · FATE · CDXS · MGTA · ALNY
2018-Q3 60% 60% 60% FMI · ONCE · MYOK · SAGE · AGIO · BLUE · CDXS · FATE · ALNY · MGTA LOXO · BPMC · MYOK · AGIO · SAGE · BLFS · FATE · NVTAQ · BLUE · ONCE
2018-Q4 90% 90% 90% LOXO · BPMC · MYOK · BLFS · AGIO · SAGE · FATE · BLUE · NVTAQ · ONCE LOXO · MYOK · BPMC · CDXS · ONCE · BLUE · FATE · SAGE · BLFS · NVTAQ
2019-Q1 80% 80% 80% LOXO · BPMC · MYOK · ONCE · BLUE · CDXS · BLFS · FATE · SAGE · ALNY ONCE · BPMC · MYOK · SAGE · BLUE · NVTAQ · FATE · MGTA · BLFS · ALNY
2019-Q2 80% 80% 80% ONCE · MYOK · BPMC · SAGE · BLUE · NVTAQ · FATE · ALNY · MGTA · BLFS ONCE · NVTAQ · BPMC · CDXS · SAGE · MYOK · FATE · SRPT · BLUE · ALNY
2019-Q3 90% 90% 90% CDXS · NVTAQ · BPMC · ONCE · SAGE · MYOK · SRPT · FATE · ALNY · BLUE ONCE · NVTAQ · CDXS · BPMC · SRPT · MYOK · BLUE · SAGE · ALNY · BLFS
2019-Q4 70% 70% 70% ONCE · NVTAQ · CDXS · SRPT · BPMC · BLUE · MYOK · SAGE · ALNY · BLFS SRPT · BLUE · CDXS · BPMC · MYOK · ALNY · NVTAQ · CNST · BOLD · FATE
2020-Q1 90% 90% 90% SRPT · BLUE · CDXS · BPMC · MYOK · ALNY · NVTAQ · CNST · BOLD · FATE BPMC · SRPT · ALNY · FATE · CDXS · BLUE · NVTAQ · MYOK · AGIO · CNST
2020-Q2 90% 90% 90% BPMC · SRPT · ALNY · FATE · CDXS · BLUE · NVTAQ · MYOK · AGIO · TWST NVTAQ · BPMC · FATE · SRPT · MYOK · ALNY · BLFS · BLUE · AGIO · CDXS
2020-Q3 80% 80% 80% NVTAQ · BPMC · FATE · BLFS · ALNY · SRPT · MYOK · BLUE · AGIO · CDXS NVTAQ · BLFS · RLAY · BPMC · FATE · MYOK · ALNY · TWST · SRPT · AGIO
2020-Q4 70% 70% 70% NVTAQ · BLFS · RLAY · BPMC · FATE · MYOK · ALNY · TWST · SRPT · AGIO NVTAQ · BLFS · FATE · EXAS · BPMC · RLAY · TWST · PACB · DNLI · AGIO
2021-Q1 90% 90% 90% NVTAQ · BLFS · FATE · EXAS · BPMC · RLAY · TWST · PACB · AGIO · DNLI NVTAQ · EXAS · FATE · BLFS · PACB · BPMC · ALNY · TWST · RLAY · AGIO
2021-Q2 80% 80% 80% NVTAQ · EXAS · FATE · BLFS · PACB · BPMC · ALNY · TWST · AGIO · RLAY NVTAQ · BLFS · FATE · EXAS · VERV · PACB · ALNY · BPMC · TWST · DNLI
2021-Q3 80% 80% 80% NVTAQ · BLFS · EXAS · FATE · VERV · ALNY · PACB · BPMC · TWST · DNLI NVTAQ · BLFS · EXAS · PACB · FATE · ALNY · MXCT · BPMC · SLGC · VERV
2021-Q4 90% 90% 90% NVTAQ · BLFS · EXAS · PACB · FATE · ALNY · MXCT · BPMC · SLGC · VERV BLFS · EQRX · FATE · NVTAQ · ALNY · BPMC · PACB · EXAS · SLGC · MXCT
2022-Q1 90% 90% 90% BLFS · EQRX · FATE · NVTAQ · PACB · ALNY · BPMC · EXAS · SLGC · MXCT BLFS · ALNY · EQRX · FATE · RLAY · SLGC · BPMC · MXCT · NVTAQ · EXAS
2022-Q2 80% 80% 80% BLFS · EQRX · ALNY · FATE · RLAY · SLGC · BPMC · MXCT · NVTAQ · EXAS EQRX · ALNY · BLFS · RLAY · MXCT · BPMC · SLGC · FATE · SRPT · VERV
2022-Q3 80% 80% 80% EQRX · ALNY · BLFS · RLAY · MXCT · BPMC · SLGC · FATE · VERV · RVMD EQRX · BLFS · SRPT · ALNY · BPMC · VERV · RLAY · ILMN · MXCT · RVMD
2022-Q4 100% 100% 100% EQRX · BLFS · SRPT · ALNY · BPMC · RLAY · VERV · ILMN · MXCT · RVMD SRPT · BLFS · EQRX · ALNY · ILMN · BPMC · RVMD · MXCT · RLAY · VERV
2023-Q1 60% 60% 60% SRPT · BLFS · EQRX · ALNY · ILMN · BPMC · RVMD · MXCT · RLAY · VERV BLFS · RLAY · EQRX · ILMN · ALNY · NTLA · PLRX · RVMD · EXAS · WGS
2023-Q2 70% 70% 70% BLFS · RLAY · EQRX · ILMN · NTLA · PLRX · ALNY · WGS · RVMD · EXAS BLFS · SRPT · RLAY · EQRX · ALNY · NTLA · RVMD · EXAS · VERV · GPCR
2023-Q3 90% 90% 90% BLFS · SRPT · RLAY · EQRX · NTLA · ALNY · RVMD · GPCR · EXAS · VERV SRPT · BLFS · EQRX · GPCR · RLAY · RVMD · VERV · NTLA · EXAS · SLGC
2023-Q4 80% 80% 80% SRPT · BLFS · EQRX · GPCR · RLAY · RVMD · VERV · NTLA · EXAS · SLGC RVMD · BLFS · SRPT · RLAY · NTLA · VERV · ALNY · SLGC · EXAS · BPMC
2024-Q1 70% 70% 70% RVMD · BLFS · SRPT · RLAY · NTLA · VERV · ALNY · SLGC · EXAS · BPMC RVMD · LAB · BLFS · SRPT · RLAY · ALNY · RNAM · GPCR · EXAS · VERV
2024-Q2 70% 70% 70% RVMD · LAB · BLFS · SRPT · RLAY · ALNY · RNAM · GPCR · EXAS · VERV BLFS · RVMD · SRPT · LAB · WGS · RNAM · RLAY · ILMN · NTLA · ALNY
2024-Q3 90% 90% 90% BLFS · SRPT · RVMD · LAB · WGS · RNAM · ILMN · RLAY · NTLA · ALNY BLFS · RVMD · WGS · LAB · SRPT · ILMN · RNAM · RLAY · ALNY · EXAS
2024-Q4 90% 90% 90% BLFS · RVMD · WGS · LAB · SRPT · ILMN · RNAM · RLAY · NTLA · EXAS WGS · BLFS · RVMD · SRPT · LAB · ILMN · RNAM · CDXS · RLAY · EXAS
2025-Q1 70% 70% 70% WGS · BLFS · RVMD · SRPT · LAB · ILMN · RNAM · CDXS · RLAY · EXAS WGS · BLFS · RVMD · LAB · RNAM · SRPT · ILMN · ALNY · BPMC · BEAM
2025-Q2 70% 70% 70% WGS · BLFS · RVMD · LAB · RNAM · SRPT · ILMN · ALNY · BEAM · BPMC WGS · BLFS · RVMD · LAB · ILMN · RNAM · VERV · RLAY · ALNY · GPCR
2025-Q3 90% 90% 90% WGS · BLFS · RVMD · LAB · ILMN · RNAM · VERV · RLAY · GPCR · ALNY WGS · BLFS · RVMD · LAB · RNAM · RLAY · ILMN · GPCR · BEAM · ALNY
2025-Q4 90% 90% 90% WGS · BLFS · RVMD · LAB · RNAM · RLAY · GPCR · ILMN · BEAM · TEM WGS · RVMD · BLFS · LAB · RLAY · GPCR · ILMN · RNAM · BEAM · GH
2026-Q1 80% 80% 80% WGS · RVMD · BLFS · LAB · RLAY · GPCR · ILMN · RNAM · BEAM · GH RVMD · WGS · RLAY · BLFS · LAB · ILMN · GPCR · TXG · DNLI · BEAM
2026-Q2 80% 80% 80% RVMD · WGS · RLAY · BLFS · LAB · ILMN · TXG · GPCR · DNLI · GH RVMD · RLAY · WGS · BLFS · ILMN · LAB · GPCR · DNLI · NGNE · BEAM
2026-Q3 ★ 70% 70% 70% RVMD · RLAY · WGS · BLFS · ILMN · LAB · GPCR · DNLI · NGNE · BEAM RVMD · RLAY · WGS · BLFS · ILMN · GRAL · TXG · LAB · NGNE · SRRK

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings24 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-17.47%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return-0.46%vs benchmark
Barra annualised vol40.8%Model estimate
Realised vol52.6%Annualised in window
Weighted beta1.28Raw exposure
Factor / specific risk66% / 34%Share of variance
Top-10 concentration84.0%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Casdin CapitalQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-17.47%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return-0.46%Portfolio − benchmark
Arithmetic return sum-17.37%Difference vs compounded is the cross term
Weighted raw beta1.28Weighted holding betas
Realised volatility (annualised)52.58%Daily returns in window
Barra model volatility (annualised)40.85%Factor + specific
Factor share of variance66.0%Barra factors
Specific share of variance34.0%Stock residuals
Reported value$2.08B13F long US equity

2. Return attribution

The -17.37% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +0.95% 5.5%
Momentum & Growth 3 -7.10% -40.9%
Volatility & Tail Risk 7 -2.15% -12.4%
Industry 12 +6.26% 36.0%
Specific 1 -15.33% -88.3%
Return attribution (style + industry, %)-10.8-5.4+0.0+5.4+10.8Turnover-0.28Growth+0.55Skewness-0.80Amihud Illiquidity-0.85Max Drawdown+0.91Kurtosis-1.73Beta+1.88Non-linear Size+1.91Size+2.44Mid Cap-2.55Health Care+6.33Residual Volatility+7.55Momentum-7.68Historical Volatility-9.96
Factor Type Exposure Factor return Contribution Share of |return|
Residual Volatility Style +2.29 +3.29% +7.55% 43.5%
Health Care Industry +0.91 +6.98% +6.33% 36.4%
Size Style -1.25 -1.95% +2.44% 14.1%
Non-linear Size Style +1.89 +1.01% +1.91% 11.0%
Beta Style +0.42 +4.44% +1.88% 10.8%
Max Drawdown Style -0.52 -1.76% +0.91% 5.2%
Growth Style +0.32 +1.75% +0.55% 3.2%
Liquidity Style +0.77 +0.36% +0.28% 1.6%
Information Technology Industry +0.02 -5.13% -0.09% -0.5%
Turnover Style +0.06 -4.80% -0.28% -1.6%
Skewness Style +0.18 -4.39% -0.80% -4.6%
Amihud Illiquidity Style +1.91 -0.45% -0.85% -4.9%
Kurtosis Style -0.23 +7.51% -1.73% -10.0%
Mid Cap Style +1.32 -1.94% -2.55% -14.7%
Momentum Style +1.92 -4.00% -7.68% -44.2%
Historical Volatility Style +0.71 -14.00% -9.96% -57.3%
Specific Specific — — -15.33% -88.3%

3. Risk attribution

Annualised volatility is 40.85%; factor risk explains 66.0% of variance and specific risk 34.0%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-36.7-18.3+0.0+18.3+36.7Information Technology+0.24Non-linear Size+0.43Industrials+1.15Growth+1.91Liquidity+2.09Amihud Illiquidity+2.73Historical Volatility+3.35Size+4.01Mid Cap+4.70Beta+4.94Residual Volatility+11.80Health Care+14.11Momentum+14.72Specific+33.95
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 34.0% +13.87% 13.9%
Momentum Style +1.92 14.7% +6.01% 6.0%
Health Care Industry +0.91 14.1% +5.76% 5.8%
Residual Volatility Style +2.29 11.8% +4.82% 4.8%
Beta Style +0.42 4.9% +2.02% 2.0%
Mid Cap Style +1.32 4.7% +1.92% 1.9%
Size Style -1.25 4.0% +1.64% 1.6%
Historical Volatility Style +0.71 3.4% +1.37% 1.4%
Amihud Illiquidity Style +1.91 2.7% +1.12% 1.1%
Liquidity Style +0.77 2.1% +0.85% 0.8%
Growth Style +0.32 1.9% +0.78% 0.8%
Industrials Industry +0.08 1.1% +0.47% 0.5%
Non-linear Size Style +1.89 0.4% +0.18% 0.2%
Information Technology Industry +0.02 0.2% +0.10% 0.1%
Max Drawdown Style -0.52 -0.2% -0.09% -0.1%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.6-0.50.51.62.6Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.25 +2.10 -3.35
Non-linear Size +1.89 +1.68 +0.22
Mid Cap +1.32 +0.13 +1.19
Beta +0.42 +1.29 -0.87
Momentum +1.92 +0.72 +1.20
Short-term Reversal +0.04 -0.64 +0.68
Residual Volatility +2.29 -0.40 +2.70
Historical Volatility +0.71 +0.86 -0.15
Liquidity +0.77 +0.11 +0.66
Amihud Illiquidity +1.91 +1.16 +0.75
Turnover +0.06 +0.21 -0.15
Growth +0.32 +0.58 -0.27
Leverage (Downside Vol) +0.00 +0.14 -0.14
Skewness +0.18 +0.24 -0.06
Kurtosis -0.23 +0.21 -0.45
Max Drawdown -0.52 -0.08 -0.43

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.118.145.372.599.7Communication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryInformation TechnologyIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 1.7% 73.6% -20.93% -22.33% +3.74% +1.03% -1.01% +16.09%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 7.7% 11.1% -29.70% +4.36% -0.73% -3.78% +1.15% -2.78%
Health Care 90.6% 1.7% -17.04% +8.29% +22.59% -0.44% -22.51% -15.58%
Total +23.17% -3.31% -22.25% -2.38%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RVMD REVOLUTION MEDICINES INC Health Care 25.43% -18.70% -4.76% Hold
RLAY RELAY THERAPEUTICS INC Health Care 13.91% -4.32% -0.60% Hold
WGS GENEDX HOLDINGS CORP Health Care 12.88% -29.43% -3.79% Hold
BLFS BIOLIFE SOLUTIONS INC Health Care 8.40% -0.62% -0.05% Reduce
ILMN ILLUMINA INC Health Care 6.97% -27.65% -1.93% Hold
GRAL GRAIL INC Health Care 4.58% -24.64% -1.13% Add
TXG 10X GENOMICS INC Industrials 4.56% -39.14% -1.79% Hold
LAB STANDARD BIOTOOLS INC Industrials 3.16% -16.08% -0.51% Hold
NGNE NEUROGENE INC Health Care 2.12% -16.25% -0.34% Add
SRRK SCHOLAR ROCK HLDG CORP Health Care 1.97% -7.82% -0.15% Add
PSNL PERSONALIS INC Health Care 1.80% -9.09% -0.16% Reduce
BEAM BEAM THERAPEUTICS INC Health Care 1.76% -14.36% -0.25% Add
TEM TEMPUS AI INC Information Technology 1.67% -20.93% -0.35% New
GH GUARDANT HEALTH INC Health Care 1.59% -19.25% -0.30% Hold
GPCR STRUCTURE THERAPEUTICS INC Health Care 1.55% -40.61% -0.63% Reduce
ALNY ALNYLAM PHARMACEUTICALS INC Health Care 1.42% -35.26% -0.50% Add
DNLI DENALI THERAPEUTICS INC Health Care 1.24% -12.53% -0.16% Reduce
HIMS HIMS & HERS HEALTH INC Health Care 1.15% -37.70% -0.43% Add
MAZE MAZE THERAPEUTICS INC Health Care 1.10% +24.72% +0.27% Hold
TSHA TAYSHA GENE THERAPIES INC Health Care 0.91% -16.63% -0.15% Add
Contribution rank Symbol Sector Weight Return Contribution
1 MAZE Health Care 1.10% +24.72% +0.27%
2 MRNA Health Care 0.69% +11.79% +0.08%
3 CTNM Health Care 0.10% -27.94% -0.03%
4 NTLA Health Care 0.21% -18.24% -0.04%
5 BLFS Health Care 8.40% -0.62% -0.05%
6 TSHA Health Care 0.91% -16.63% -0.15%
7 SRRK Health Care 1.97% -7.82% -0.15%
8 DNLI Health Care 1.24% -12.53% -0.16%
9 GRAL Health Care 4.58% -24.64% -1.13%
10 TXG Industrials 4.56% -39.14% -1.79%
11 ILMN Health Care 6.97% -27.65% -1.93%
12 WGS Health Care 12.88% -29.43% -3.79%
13 RVMD Health Care 25.43% -18.70% -4.76%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -17.47%, versus -17.01% for the QQQ synthetic benchmark — an excess of -0.46%.
  2. Return attribution: the largest positive style/industry contributions came from Residual Volatility +7.55%, Health Care +6.33%, Size +2.44%; the largest drags came from Historical Volatility -9.96%, Momentum -7.68%, Mid Cap -2.55%. Specific (stock-level) return contributed -15.33%.
  3. Risk attribution: Barra model volatility is 40.85% annualised; factor risk explains 66% of variance and specific risk 34%. The largest factor risk sources are Momentum 14.7%, Health Care 14.1%, Residual Volatility 11.8%.
  4. Style tilt: size -1.25, momentum +1.92, volatility +0.71, liquidity +0.77; the weighted raw beta is 1.28. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+88.9 pp), the largest underweight is Information Technology (-72.0 pp). Allocation contributed +23.17%, selection -3.31% and interaction -22.25%.
  6. Concentration: the top-10 positions are 84.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Casdin Capital buy in 2026-Q3?

In its 2026-Q3 13F filing, Casdin Capital reported 47 equity positions worth $2.29B in aggregate; its largest disclosed positions were RVMD ($529.02M), RLAY ($289.44M), WGS ($268.03M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $2.29B of long equity holdings across 47 positions as of 2026-Q3. Top-10 holdings account for 76.4% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →